|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01011 NT PHARMA
Nominal 
0.420 +0.060 (+16.667%) Non-current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 | 0 | 0 |
| Property, plant, equip. & others | 4,119 | 555.892% | 628 | 543 | 944 | 495,717 |
| Land & other Lease Assets | 0 | -- | 0 | 0 | 0 | 0 |
| Intangible Assets | 280,418 | -- | 0 | 0 | 195 | 158,985 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 312,960 | 277,013 |
| Other Non-current Assets | 328,989 | -0.715% | 331,358 | 317,347 | 2,746 | 569 |
| 613,526 | 84.805% | 331,986 | 317,890 | 316,845 | 932,284 | |
Current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | 2,055 | 412.469% | 401 | 168 | 0 | 10,318 | |
| Trade Receivables | 12,117 | 574.666% | 1,796 | 0 | 10,052 | 33,666 | |
| Cash & Bank Balances | 11,909 | 64.922% | 7,221 | 9,623 | 1,520 | 5,931 | |
| Other Current Assets | 3,245 | -45.407% | 5,944 | 6,394 | 705 | 23,519 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 29,326 | 90.900% | 15,362 | 16,185 | 12,277 | 73,434 | ||
Current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | 4,088 | 53.626% | 2,661 | 498 | 974 | 8,477 | ||
| S-T Debt & Leases | 334,991 | 5.805% | 316,613 | 367,836 | 341,342 | 825,991 | ||
| Other Current Liabilities | 307,111 | 1.752% | 301,822 | 356,731 | 322,771 | 335,225 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 646,190 | 4.040% | 621,096 | 725,065 | 665,087 | 1,169,693 | |||
| Net Current Assets | (616,864) | 1.837% | (605,734) | (708,880) | (652,810) | (1,096,259) | ||
| Total Assets Less Current Liabilities | (3,338) | -98.781% | (273,748) | (390,990) | (335,965) | (163,975) | ||
Non-current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | 0 | -- | 85 | 8,118 | 3,600 | 463 | |||
| Other Non-current Liabilities | 47,960 | -- | 0 | 0 | 0 | 77,220 | |||
| 47,960 | 56323.529% | 85 | 8,118 | 3,600 | 77,683 | ||||
Capital and Reserves
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | 5 | 25.000% | 4 | 1 | 1 | 1 | ||||
| Reserves | (111,263) | -59.337% | (273,623) | (399,109) | (339,566) | (241,659) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | (111,258) | -59.338% | (273,619) | (399,108) | (339,565) | (241,658) | ||||
| Non-controlling Interests | 59,960 | -- | (214) | 0 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| (51,298) | -81.267% | (273,833) | (399,108) | (339,565) | (241,658) | |||||
Commitments and Contingent Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | -- | 0 | 1,440 | 20,000 |
| Contingent Liabilities | -- | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 24/08/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -18,433 |
| %Change | 9.032% |
| EPS / (LPS) | RMB -0.022 |
| NBV Per Share (¥) | RMB -0.117 |